TBR323

N/A

Report date: 2024/08/26 10:53:04
First In Class

Base Information

Drug NameTBR323
Drug Alias NameTBR323TBR-323
ClassificationOther
Mechanisms of ActionAnti-C-C chemokine receptor type 8
TargetsC-C chemokine receptor type 8
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTwinpig Biolab Inc
China Registration ClassN/A

Develop Information

Active CompaniesTwinpig Biolab Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A